113 related articles for article (PubMed ID: 11454520)
1. Overnight dexamethasone suppression of cortisol is associated with radiocholesterol uptake patterns in adrenal incidentalomas.
Barzon L; Fallo F; Sonino N; Boscaro M
Eur J Endocrinol; 2001 Aug; 145(2):223-4. PubMed ID: 11454520
[No Abstract] [Full Text] [Related]
2. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas.
Valli N; Catargi B; Ronci N; Vergnot V; Leccia F; Ferriere JM; Chene G; Grenier N; Laurent F; Tabarin A
Eur J Endocrinol; 2001 Apr; 144(4):401-8. PubMed ID: 11275951
[TBL] [Abstract][Full Text] [Related]
3. Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates.
Barzon L; Scaroni C; Sonino N; Fallo F; Gregianin M; Macrì C; Boscaro M
J Clin Endocrinol Metab; 1998 Jan; 83(1):55-62. PubMed ID: 9435416
[TBL] [Abstract][Full Text] [Related]
4. The case for high-dose dexamethasone suppression testing preoperatively in aldosterone-producing adenoma to exclude cosecretion of cortisol.
Gordon RD
Am J Hypertens; 2008 Nov; 21(11):1176. PubMed ID: 18941449
[No Abstract] [Full Text] [Related]
5. Some aldosterone-producing adrenal tumours also secrete cortisol, but present clinically as primary aldosteronism.
Tunny TJ; Klemm SA; Gordon RD
Clin Exp Pharmacol Physiol; 1990 Mar; 17(3):167-71. PubMed ID: 2160340
[TBL] [Abstract][Full Text] [Related]
6. A black adrenocortical adenoma causing Cushing's syndrome not imaged by radiocholesterol scintigraphy.
Reschini E; Baldini M; Cantalamessa L
Eur J Nucl Med; 1990; 17(3-4):185-7. PubMed ID: 2279500
[TBL] [Abstract][Full Text] [Related]
7. Pre-Cushing's syndrome not recognized by conventional dexamethasone suppression-tests in an adrenal "incidentaloma" patient.
Torlontano M; Zingrillo M; D'Aloiso L; Ghiggi MR; Di Cerbo A; Scillitani A; Petracca-Ciavarella G; Liuzzi A
J Endocrinol Invest; 1997 Sep; 20(8):501-4. PubMed ID: 9364256
[TBL] [Abstract][Full Text] [Related]
8. Secreting ectopic adrenal adenoma: A rare condition to be aware of.
Zhao Y; Guo H; Zhao Y; Shi B
Ann Endocrinol (Paris); 2018 Apr; 79(2):75-81. PubMed ID: 29525561
[TBL] [Abstract][Full Text] [Related]
9. A case of ganglioneuroma in which 131I-6beta-iodomethyl-19-norcholest-5(10)-en-3beta-ol scintigraphy showed high uptake in the adrenal gland leading to a misdiagnosis.
Fukumitsu N; Ashida H; Ogi S; Uchiyama M; Mori Y; Ikemoto I; Sakamoto N; Tojo K; Kawakami M
Ann Nucl Med; 2006 Jan; 20(1):69-73. PubMed ID: 16485578
[TBL] [Abstract][Full Text] [Related]
10. 131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas.
Bardet S; Rohmer V; Murat A; Guillemot C; Maréchaud R; Chupin M; Lecomte P; Simon D; Delemer B; Schneebelli S; Beutter D; Jacquin V; Peltier P; Charbonnel B
Clin Endocrinol (Oxf); 1996 May; 44(5):587-96. PubMed ID: 8762736
[TBL] [Abstract][Full Text] [Related]
11. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours.
Maurea S; Klain M; Caraco C; Ziviello M; Salvatore M
Nucl Med Commun; 2002 Oct; 23(10):951-60. PubMed ID: 12352593
[TBL] [Abstract][Full Text] [Related]
13. Patients with extra-adrenal malignancies and adrenal lesions have similar rates of subclinical hypercortisolism compared with patients with true adrenal incidentalomas.
Chrisoulidou A; Rakitzi P; Boudina M; Apostolidou-Kiouti F; Poimenidou E; Papanikolaou A; Devlioti A; Rallis G; Pazaitou-Panayiotou K
Hormones (Athens); 2019 Mar; 18(1):85-89. PubMed ID: 30737657
[TBL] [Abstract][Full Text] [Related]
14. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
[TBL] [Abstract][Full Text] [Related]
15. Radionuclide imaging of the adrenal glands.
Chatal JF; Charbonnel B; Guihard D
Clin Nucl Med; 1978 Feb; 3(2):71-6. PubMed ID: 657660
[No Abstract] [Full Text] [Related]
16. Does the corticoadrenal adenoma with "pre-Cushing's syndrome" exist?
Charbonnel B; Chatal JF; Ozanne P
J Nucl Med; 1981 Dec; 22(12):1059-61. PubMed ID: 6273512
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing's syndrome and non-functional adrenal tumor.
Morio H; Terano T; Yamamoto K; Tomizuka T; Oeda T; Saito Y; Tamura Y; Sasano H
Endocr J; 1996 Aug; 43(4):387-96. PubMed ID: 8930526
[TBL] [Abstract][Full Text] [Related]
18. Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma.
Fernández-Real JM; Engel WR; Simó R; Salinas I; Webb SM
Clin Endocrinol (Oxf); 1998 Jul; 49(1):53-61. PubMed ID: 9797847
[TBL] [Abstract][Full Text] [Related]
19. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
Tsagarakis S; Roboti C; Kokkoris P; Vasiliou V; Alevizaki C; Thalassinos N
Clin Endocrinol (Oxf); 1998 Aug; 49(2):165-71. PubMed ID: 9828902
[TBL] [Abstract][Full Text] [Related]
20. Markedly increased 18F-FDG uptake in a nonfunctioning adrenal adenoma mimicking malignancy.
Treglia G; Oragano L; Fadda G; De Gaetano AM; Raffaelli M; Rufini V
Clin Nucl Med; 2013 Aug; 38(8):e333-5. PubMed ID: 23486332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
